Lymphedema Prevention Program
ImpediMed’s Test, Trigger, Treat™ protocol for lymphedema prevention.
Lymphedema is one of the most feared consequences of cancer treatment among survivors. Early detection is critical to preventing lymphedema from becoming a chronic condition. SOZO® with L-Dex® helps healthcare professionals to identify at-risk patients early and intervene before lymphedema becomes irreversible.
Early detection of secondary lymphedema using L-Dex combined with at-home intervention using standard compression therapy has been shown reduce the progression of lymphedema by 95%1.
In the past, the onset of lymphedema was too difficult to detect using standard measurement techniques. Now, SOZO with L-Dex technology aids in detecting lymphedema at the subclinical level, or Stage 0, before visible swelling and the condition is irreversible. By the time patients experience lymphedema symptoms, it may be too late to reverse the condition.
Early detection of lymphedema at the subclinical level before any swelling is visible is critical. SOZO with L-Dex delivers a precise snapshot of fluid status in less than 30 seconds2. Early detection of fluid accumulation coupled with standard, at-home compression treatment has been shown to reduce lymphedema progression by 95%1.
ImpediMed is proud to partner with LIVE Today Foundation and Lymphatic Research & Education Network to grow awareness for lymphatic diseases and their impact on patients and to improve access to care.